
Endobronchial Ultrasound Biopsy Market Report 2026
Global Outlook – By Procedure Type (Convex Probe Endobronchial Ultrasound Guided Biopsy, Radial Probe Endobronchial Ultrasound Guided Biopsy), By Product Type (Endobronchial Ultrasound Scopes, Biopsy Needles And Sampling Consumables, Ultrasound Processors And Imaging Systems, Accessories And Ancillary Devices), By Usability (Reusable Devices, Single Use Devices), By Application (Lung Cancer Diagnosis And Staging, Granulomatous And Infectious Disease Evaluation, Other Applications), By End User (Hospitals And Specialty Cancer Centers, Ambulatory Surgical Centers, Diagnostic Imaging And Biopsy Centers) – Market Size, Trends, Strategies, and Forecast to 2035
Endobronchial Ultrasound Biopsy Market Overview
• Endobronchial Ultrasound Biopsy market size has reached to $0.66 billion in 2025 • Expected to grow to $0.93 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Increasing Incidence Of Lung Cancer Driving The Market Growth Due To Rising Diagnostic Needs And Early Detection Efforts • Market Trend: Advancements In Minimally Invasive Imaging For Enhanced Pulmonary Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Endobronchial Ultrasound Biopsy Market?
Endobronchial ultrasound biopsy is a minimally invasive procedure that uses a bronchoscope with an integrated ultrasound probe to visualize structures within and around the airways. It enables real-time guidance to collect tissue samples from lymph nodes or masses in the chest for diagnostic purposes. The technique enhances accuracy in diagnosing lung diseases and mediastinal abnormalities while minimizing the need for more invasive surgical methods. The main procedure types of endobronchial ultrasound biopsy include convex probe endobronchial ultrasound guided biopsy and radial probe endobronchial ultrasound guided biopsy. Convex probe endobronchial ultrasound guided biopsy refers to a minimally invasive technique that uses a convex ultrasound bronchoscope to obtain real-time guided tissue samples from lymph nodes and lung lesions. The different product types include endobronchial ultrasound scopes, biopsy needles and sampling consumables, ultrasound processors and imaging systems, and accessories and ancillary devices and the usability types include reusable devices and single use devices. They find application in lung cancer diagnosis and staging, granulomatous and infectious disease evaluation, and other applications, serving end users including hospitals and specialty cancer centers, ambulatory surgical centers, and diagnostic imaging and biopsy centers.
What Is The Endobronchial Ultrasound Biopsy Market Size and Share 2026?
The endobronchial ultrasound biopsy market size has grown strongly in recent years.It will grow from $0.66 billion in 2025 to $0.71 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of lung cancer cases, increasing adoption of minimally invasive diagnostic procedures, growth in hospital-based bronchoscopy units, advancements in ultrasound-guided biopsy technologies, expanding awareness of early thoracic disease diagnosis.What Is The Endobronchial Ultrasound Biopsy Market Growth Forecast?
The endobronchial ultrasound biopsy market size is expected to see strong growth in the next few years.It will grow to $0.93 billion by 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for precision-guided pulmonary diagnostics, growing adoption of single use biopsy devices, expansion of AI-enabled bronchoscopy imaging systems, rising investments in cancer diagnostic infrastructure, increasing utilization of outpatient and ambulatory biopsy procedures.Major trends in the forecast period include increasing adoption of minimally invasive mediastinal biopsy procedures, rising preference for single use endobronchial ultrasound devices, growing demand for real-time lymph node sampling accuracy, expansion of lung cancer screening and diagnostic programs, increasing use of advanced ultrasound-guided peripheral lung lesion localization.Global Endobronchial Ultrasound Biopsy Market Segmentation
1) By Procedure Type: Convex Probe Endobronchial Ultrasound Guided Biopsy, Radial Probe Endobronchial Ultrasound Guided Biopsy 2) By Product Type: Endobronchial Ultrasound Scopes, Biopsy Needles And Sampling Consumables, Ultrasound Processors And Imaging Systems, Accessories And Ancillary Devices 3) By Usability: Reusable Devices, Single Use Devices 4) By Application: Lung Cancer Diagnosis And Staging, Granulomatous And Infectious Disease Evaluation, Other Applications 5) By End User: Hospitals And Specialty Cancer Centers, Ambulatory Surgical Centers, Diagnostic Imaging And Biopsy Centers Subsegments: 1) By Convex Probe Endobronchial Ultrasound Guided Biopsy: Transbronchial Needle Aspiration Guided Procedures, Real Time Lymph Node Sampling Procedures, Mediastinal Staging Biopsy Procedures, Central Lung Lesion Biopsy Procedures, Combined Bronchoscopic Ultrasound Guided Sampling Procedures 2) By Radial Probe Endobronchial Ultrasound Guided Biopsy: Peripheral Lung Lesion Localization Procedures, Guide Sheath Assisted Biopsy Procedures, Transbronchial Forceps Biopsy Procedures, Brush Cytology Sampling Procedures, Fluoroscopy Assisted Peripheral Biopsy ProceduresWhat Is The Driver Of The Endobronchial Ultrasound Biopsy Market?
The increasing incidence of lung cancer is expected to propel the growth of the endobronchial ultrasound biopsy industry going forward.Lung cancer is a type of malignant tumor characterized by uncontrolled cell growth in lung tissues that can invade surrounding tissue or metastasize to distant organs.The incidence of lung cancer is rising due to factors such as increased smoking prevalence and environmental exposures that elevate the risk of lung malignancy.Endobronchial ultrasound biopsy enables precise, minimally invasive sampling of lung and mediastinal tissues, allowing for accurate diagnosis, staging, and monitoring of lung cancer, which in turn guides targeted treatment decisions and improves patient outcomes.For instance, in March 2026, according to the Cancer Research UK (CRUK), a UK-based Cancer Research UK (CRUK), For women in the UK, the European age-standardised (AS) incidence rate of lung cancer is projected to increase by 2% between 2024–2026 and 2038–2040, rising from approximately 75.8 to 77.6 cases per 100,000 women per year.Therefore, the increasing incidence of lung cancer is driving the growth of the endobronchial ultrasound biopsy industry.Key Players In The Global Endobronchial Ultrasound Biopsy Market
Major companies operating in the endobronchial ultrasound biopsy market are Medtronic plc, Siemens Healthcare Private Limited, FUJIFILM Holdings Corporation, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Konica Minolta Inc., Intuitive Surgical Inc., Olympus Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., STERIS plc, Teleflex Incorporated, Canon Medical Systems Corporation, Cook Group Incorporated, CONMED Corporation, PENTAX Medical, Esaote S. p. A., Medi-Globe Technologies GmbH, ENDO-FLEX GmbH, Taewoong Medical Co. Ltd., ACE Medical Devices Private Limited, Body Vision Medical Ltd., Clinodevice S. r. l.Global Endobronchial Ultrasound Biopsy Market Trends and Insights
Major companies operating in the endobronchial ultrasound biopsy market are focusing on developing innovative products such as, next-generation EBUS bronchoscopes to enhance diagnostic accuracy and improve minimally invasive lung cancer procedures. Next-generation EBUS bronchoscopes are advanced endoscopic devices with integrated high-resolution ultrasound probes that allow real-time imaging of airways and lymph nodes, helping clinicians perform more precise, minimally invasive lung biopsies compared to traditional bronchoscopes. For instance, in September 2025, Olympus Corporation, a Japan-based medical technology company, launched the BF-UC190F EBUS bronchoscope, an innovative device designed to improve diagnostic accuracy and procedural efficiency in thoracic oncology. The BF-UC190F features a thinner, more flexible insertion tube, a high-resolution ultrasound probe, and enhanced maneuverability, enabling clinicians to access difficult-to-reach lymph nodes while reducing patient discomfort. Its ergonomic design and improved imaging capabilities support safer, faster biopsies and reduce the need for repeat procedures. This advanced bronchoscope is particularly beneficial in early lung cancer detection and staging, offering real-time guidance for needle aspiration and tissue sampling.What Are Latest Mergers And Acquisitions In The Endobronchial Ultrasound Biopsy Market?
In February 2025, Micro-Tech (Nanjing) Co. Ltd., a China-based healthcare technology company, acquired Creo Medical S. L. U. (CME) for an undisclosed amount. With this acquisition, Micro-Tech (Nanjing) Co., Ltd. aims to expand its global footprint and strengthen its distribution network across Europe by leveraging CME’s established sales channels and complementary product portfolio. Creo Medical S. L. U. (CME) is a Spain-based healthcare technology company that specializes in providing endobronchial ultrasound biopsy.Regional Insights
North America was the largest region in the endobronchial ultrasound biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Endobronchial Ultrasound Biopsy Market?
The endobronchial ultrasound biopsy market consists of revenues earned by entities by providing services such as diagnostic tissue sampling, lymph node staging, real-time ultrasound imaging, procedure planning and guidance, and post-procedural analysis and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The endobronchial ultrasound biopsy market also includes sales of needle adapters, ultrasound processors, light sources, video processors, monitor systems, guide sheaths, disposable biopsy forceps, and cytology brushes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.What is the Market Assessment and Strategic Outlook for the Endobronchial Ultrasound Biopsy Industry?
The endobronchial ultrasound biopsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the endobronchial ultrasound biopsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.What is the Market Assessment and Strategic Outlook for the Endobronchial Ultrasound Biopsy Market Report 2026?
The endobronchial ultrasound biopsy market research report is one of a series of new reports from The Business Research Company that provides endobronchial ultrasound biopsy market statistics, including endobronchial ultrasound biopsy industry global market size, regional shares, competitors with a endobronchial ultrasound biopsy market share, detailed endobronchial ultrasound biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the endobronchial ultrasound biopsy industry. This endobronchial ultrasound biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Endobronchial Ultrasound Biopsy Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.71 billion |
| Revenue Forecast In 2035 | $0.93 billion |
| Growth Rate | CAGR of 7.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Procedure Type, Product Type, Usability, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Medtronic plc, Siemens Healthcare Private Limited, FUJIFILM Holdings Corporation, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Konica Minolta Inc., Intuitive Surgical Inc., Olympus Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., STERIS plc, Teleflex Incorporated, Canon Medical Systems Corporation, Cook Group Incorporated, CONMED Corporation, PENTAX Medical, Esaote S. p. A., Medi-Globe Technologies GmbH, ENDO-FLEX GmbH, Taewoong Medical Co. Ltd., ACE Medical Devices Private Limited, Body Vision Medical Ltd., Clinodevice S. r. l. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
